{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:29:37Z","timestamp":1793690977222,"version":"4.5.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,11]]},"DOI":"10.7759\/cureus.23052","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T03:29:37Z","timestamp":1646969377000},"source":"Crossref","is-referenced-by-count":2,"title":["The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement"],"prefix":"10.7759","author":[{"given":"Najwa","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujain","family":"Allehyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Alobaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan B","family":"Albackr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifah","family":"Aldakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi S","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farjah H","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2069.79616","article-title":"Global research priorities in rheumatic fever and rheumatic heart disease","volume":"4","author":"Carapetis JR","year":"2011","unstructured":"Carapetis JR, Z\u00fchlke LJ. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol. 2011, 4:4-12. 10.4103\/0974-2069.79616","journal-title":"Ann Pediatr Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-012-0105-9","article-title":"Heart failure in pregnancy","volume":"9","author":"Rutherford JD","year":"2012","unstructured":"Rutherford JD. Heart failure in pregnancy. Curr Heart Fail Rep. 2012, 9:277-81. 10.1007\/s11897-012-0105-9","journal-title":"Curr Heart Fail Rep"},{"key":"ref3","article-title":"Valvular heart disease: diagnosis and management","volume":"55","author":"Bhandari S","year":"2007","unstructured":"Bhandari S, Subramanyam K, Trehan N. Valvular heart disease: diagnosis and management. J Assoc Physicians India. 2007, 55:575-84.","journal-title":"J Assoc Physicians India"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000185","article-title":"Medical management of rheumatic heart disease: a systematic review of the evidence","volume":"26","author":"Russell EA","year":"2018","unstructured":"Russell EA, Walsh WF, Costello B, et al.. Medical management of rheumatic heart disease: a systematic review of the evidence. Cardiol Rev. 2018, 26:187-95. 10.1097\/CRD.0000000000000185","journal-title":"Cardiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom JW","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, et al.. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013, 369:1206-14. 10.1056\/NEJMoa1300615","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme KA","year":"2003","unstructured":"Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003, 16:153-68. 10.1016\/s1521-6926(03)00021-5","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05041.x","article-title":"Hormones and pregnancy: thromboembolic risks for women","volume":"126","author":"Kujovich JL","year":"2004","unstructured":"Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol. 2004, 126:443-54. 10.1111\/j.1365-2141.2004.05041.x","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2009.02299.x","article-title":"Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin","volume":"116","author":"McLintock C","year":"2009","unstructured":"McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG. 2009, 116:1585-92. 10.1111\/j.1471-0528.2009.02299.x","journal-title":"BJOG"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek V","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al.. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018, 39:3165-241. 10.1093\/eurheartj\/ehy340","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1996.tb05959.x","article-title":"Differential binding of warfarin to maternal, foetal and non-pregnant sera and its clinical implications","volume":"48","author":"Bajoria R","year":"1996","unstructured":"Bajoria R, Sooranna SR, Contractor SF. Differential binding of warfarin to maternal, foetal and non-pregnant sera and its clinical implications. J Pharm Pharmacol. 1996, 48:486-91. 10.1111\/j.2042-7158.1996.tb05959.x","journal-title":"J Pharm Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.11.005","article-title":"Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis","volume":"32","author":"Xu Z","year":"2016","unstructured":"Xu Z, Fan J, Luo X, et al.. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis. Can J Cardiol. 2016, 32:1248.e1-9. 10.1016\/j.cjca.2015.11.005","journal-title":"Can J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308199","article-title":"Valvular heart disease and pregnancy part II: management of prosthetic valves","volume":"103","author":"Bhagra CJ","year":"2017","unstructured":"Bhagra CJ, D'Souza R, Silversides CK. Valvular heart disease and pregnancy part II: management of prosthetic valves. Heart. 2017, 103:244-52. 10.1136\/heartjnl-2015-308199","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/021849230501300107","article-title":"Anticoagulation in patients with mechanical valves during pregnancy","volume":"13","author":"Geelani MA","year":"2005","unstructured":"Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann. 2005, 13:30-3. 10.1177\/021849230501300107","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref14","article-title":"Pregnancy after mechanical mitral valve replacement","volume":"12","author":"Vural KM","year":"2003","unstructured":"Vural KM, Ozatik MA, Uncu H, Emir M, Yurdag\u00f6k O, Sener E, Tasdemir O. Pregnancy after mechanical mitral valve replacement. J Heart Valve Dis. 2003, 12:370-6.","journal-title":"J Heart Valve Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4137\/CMC.S36740","article-title":"Maternal and fetal outcomes in pregnant women with a prosthetic mechanical heart valve","volume":"10","author":"Ayad SW","year":"2016","unstructured":"Ayad SW, Hassanein MM, Mohamed EA, Gohar AM. Maternal and fetal outcomes in pregnant women with a prosthetic mechanical heart valve. Clin Med Insights Cardiol. 2016, 10:11-7. 10.4137\/CMC.S36740","journal-title":"Clin Med Insights Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.117657","article-title":"Enoxaparin treatment in women with mechanical heart valves during pregnancy","volume":"185","author":"Rowan JA","year":"2001","unstructured":"Rowan JA, McCowan LM, Raudkivi PJ, North RA. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol. 2001, 185:633-7. 10.1067\/mob.2001.117657","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.06.040","article-title":"Use of low molecular weight heparin in pregnant women with mechanical heart valves","volume":"104","author":"Yinon Y","year":"2009","unstructured":"Yinon Y, Siu SC, Warshafsky C, et al.. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol. 2009, 104:1259-63. 10.1016\/j.amjcard.2009.06.040","journal-title":"Am J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14478","article-title":"Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system","volume":"124","author":"Vause S","year":"2017","unstructured":"Vause S, Clarke B, Tower CL, Hay C, Knight M. Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system. BJOG. 2017, 124:1411-9. 10.1111\/1471-0528.14478","journal-title":"BJOG"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx032","article-title":"Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis","volume":"38","author":"D'Souza R","year":"2017","unstructured":"D'Souza R, Ostro J, Shah PS, et al.. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017, 38:1509-16. 10.1093\/eurheartj\/ehx032","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88544-the-safety-and-efficacy-of-low-molecular-weight-heparin-in-pregnant-women-with-rheumatic-heart-disease-and-valves-replacement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:04:31Z","timestamp":1793689471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88544-the-safety-and-efficacy-of-low-molecular-weight-heparin-in-pregnant-women-with-rheumatic-heart-disease-and-valves-replacement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.23052","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,11]]}}}